Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Ultragenyx Pharmaceutical Inc. | StockGist | StockGist

Companies
RARE
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings RARESCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Ultragenyx Pharmaceutical Inc.

Filed Apr 24, 2025

Accepted Apr 23, 2025, 8:00 PM ET

CIK 0001515673

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Ultragenyx Pharmaceutical Inc.

Person Type

HC

CUSIP: 90400D108

Amendment History

5 filings

SCHEDULE 13G
Original
Nov 5, 20250000315066-25-002839
SCHEDULE 13G/A
Amendment 1
Feb 10, 20250000902219-25-000076
SCHEDULE 13G/A
Amendment 2
Feb 12, 20250001020066-25-000013
SCHEDULE 13G/A
Amendment 3
Viewing
Apr 24, 20250002052113-25-001563
SCHEDULE 13G/A
Amendment 4
Latest
Mar 27, 20260000102909-26-002574

Recent Filings

Ultragenyx Pharmaceutical Inc.3 days ago

Ultragenyx Pharmaceutical Inc.1 weeks ago

Ultragenyx Pharmaceutical Inc.3 weeks ago

Ultragenyx Pharmaceutical Inc.1 months ago

Ultragenyx Pharmaceutical Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice